Acupuncture for Dizziness and Vertigo in Emergency Department

Not Applicable

Completed

• Conditions: Dizziness and Vertigo

• Registration Number: NCT06873217
• Lead Sponsor: China Medical University Hospital

Brief Summary

This study was conducted at China Medical University Hospital, Taiwan, between January 2019 and December 2023, with 345 patients diagnosed with dizziness and vertigo (ICD-10 codes R42 and H81). Patients received acupuncture in addition to standard Western medical care. The Visual Analogue Scale (VAS) was used to assess symptom severity before and after the acupuncture intervention. Secondary analyses explored the influence of ICD-10 classification, gender, and seasonality on treatment outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2025-03
• Study First Submitted: 2025-03-02
• Study First Submitted QC: 2025-03-06
• Last Update Submitted: 2025-03-06
• Study First Posted: 2025-03-12
• Last Update Posted: 2025-03-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 345

Inclusion Criteria

Patients who were diagnosed as ICD number R42 and H81

Exclusion Criteria

Patients who were not suitable to accept acupuncture or refused to accept acupuncture

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale (VAS) change	30 minutes	The primary outcome in this study was the difference of Visual Analogue Scale (VAS) before and after intervention, aiming to assess if patient's condition got better after acupuncture.; VAS is one of the pain rating scales, with the minimum value 0 and the maximum value 10, used for the first time in 1921 by Hayes and Patterson. From the patient's perspective, this spectrum appears continuous; their pain does not take discrete jumps, as a categorization of none, mild, moderate and severe would suggest. It was to capture this idea of an underlying continuum that the VAS was devised.

Trial Locations

Locations (1)

China Medical University; 🇨🇳 Taichung, Taiwan